Single agent BMS-911543 Jak2 inhibitor has distinct inhibitory effects on STAT5 signaling in genetically engineered mice with pancreatic cancer
Thomas A. Mace(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute), Gregory B. Lesinski(The Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute)
Cited by 16
Related Papers
IL-6 and PD-L1 antibody blockade combination therapy reduces tumour progression in murine models of pancreatic cancer
|Gut|2016|540
The antitumor effects of IFN-α are abrogated in a STAT1-deficient mouse
|Journal of Clinical Investigation|2003|140
The small molecule curcumin analog FLLL32 induces apoptosis in melanoma cells via STAT3 inhibition and retains the cellular response to cytokines with anti-tumor activity
|Molecular Cancer|2010|115
CD200 promotes immunosuppression in the pancreatic tumor microenvironment
|Journal for ImmunoTherapy of Cancer|2020|99